Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment
- Authors:
- Published online on: February 16, 2018 https://doi.org/10.3892/etm.2018.5876
- Pages: 3924-3928
-
Copyright: © Yuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Henoch-Schonlein purpura (HSP) is common in children, the main pathological feature is the small blood vessel inflammation caused by the accumulation of a variety of cytokines, and it recurs easily, mostly occurring in children aged 3–10 years, with less incidence among adults (1).
The main clinical features of the disease are non-thrombocytopenic purpura, arthritis, and internal organs involved, including gastrointestinal tract and kidney (2). The disease is usually acute and self-limiting, however, kidney involvement often leads to serious clinical consequences, and its prognosis depends on the severity of kidney involvement (3). HSP patients may occur with secondary renal function impairment, hematuria or proteinuria, the renal disease at this time is also known as Henoch-Schonlein purpura nephritis (HSPN) (4). IL-8 is a proinflammatory factor, IL-10 is an anti-inflammatory factor, and both of these are altered with the change in the degree of inflammation. TNF-α has a very important regulatory role for the immune function, and the level of urinary protein is closely related to the degree of renal function impairment.
In the present study, by detecting the levels of TNF-α, IL-8 and IL in serum of HSP combined with renal function impairment patient (HSPN group) and HSP combined without renal function impairment (NHSPN group) and healthy people, we explored the relationship between inflammatory factors such as IL-8, IL-10, TNF-α and HSPN.
Materials and methods
General information
Patients with Henoch-Schonlein purpura (HSP) admitted into The Affiliated Hospital of Jining Medical University from June, 2016 to June, 2017 were included, divided into the NHSPN group (n=58) and HSPN group (n=54) according to whether or not combined with HSPN. The NHSPN group comprised 31 males and 27 females, aged 7.2±2.5 years, and the HSPN group had 28 males and 26 females, aged 7.1±2.3 years. In addition, 50 healthy individuals were randomly selected as the control group, including 27 males and 25 females, with an average age of 7.0±2.1 years. There was no significant difference in sex and age in the three groups (P>0.05).
This study was approved by the ethics committee of The Affiliated Hospital of Jining Medical University (Shandong, China). Signed written informed consents were obtained from all the participants before the study.
According to the classification of HSPN at the Zhuhai meeting in 2000, 15 cases of simple proteinuria, 11 cases of acute nephritis, 13 cases of chronic nephritis, and 15 cases of nephrotic syndrome were diagnosed in HSPN group. Of these, 15 cases had light nephritis, and 39 cases had severe nephritis. There was no significant difference in age, sex and weight between the subgroups of HSPN group (P>0.05). Specific distribution is provided in Table I. All the included cases were consistent with the Henoch-Schonlein purpura classification criteria of the American Rheumatology Association (5). Patients were excluded from the HSPN group if systemic vasculitis, thrombocytopenic purpura, other systemic immune diseases (such as systemic lupus erythematosus), dermato-myositis, diabetes was detected, and if renal biopsy results did not render them eligible for this group.
Methods
Venous blood (2 ml) was taken from the subjects in the morning following fasting, and centrifuged at 2,300 × g for 10 min. The serum at the lower part of the test tube was stored at −20°C. The collected blood samples were assayed for cytokine level using the ELISA kit (Sigma, St. Louis, MO, USA). Determination of the urinary protein level was performed by MA-4210 urine analyzer (Guilin Huatong Medical Instrument Co., Ltd., Guangxi, China), the urine reagent strip was immersed in urine for 1 min, and then removed and placed into the urine analyzer for quantitative detection.
Statistical analysis
SPSS 11.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Measurement data are presented as mean ± SD. Comparisons between groups was tested with ANOVA and SNK test was used as post hoc test. Enumeration data were analyzed using Chi-square analysis. The correlation between urinary protein content and serum factor in patients with HSPN combined with renal impairment was analyzed by Pearson's linear correlation analysis. P<0.05 was considered to indicate a statistically significant difference.
Results
TNF-α levels in the three groups
The levels of TNF-α in the HSPN and NHSPN groups were significantly higher than those in the control group (P<0.05). The level of TNF-α in HSPN group was higher than that in NHSPN group (P<0.05) (Fig. 1).
IL-8 levels in three groups
The levels of IL-8 in the HSPN and NHSPN groups were significantly higher than those in the control group, and the difference was statistically significant (P<0.05). There was no significant difference in IL-8 level between HSPN group and NHSPN group (P>0.05) (Fig. 2).
IL-10 level in the three groups
The levels of IL-10 in the HSPN and NHSPN groups were significantly higher than those in the control group, and the difference was statistically significant (P<0.05). There was no significant difference in IL-10 level between the HSPN and NHSPN groups (P>0.05) (Fig. 3).
Levels of TNF-α, IL-8 and IL-10 in HSPN group
The levels of TNF-α, IL-8 and IL-10 in the acute nephritis, chronic nephritis and nephrotic syndrome groups were higher than those in the simple proteinuria group (P<0.05, P<0.01). Levels of TNF-α, IL-8 and IL-10 in the acute nephritis group were significantly higher than those in the chronic nephritis and nephrotic syndrome groups (P<0.05). There was no significant difference between the chronic nephritis and nephrotic syndrome groups (P>0.05) (Fig. 4).
Correlation between urinary protein content and serum TNF-α, IL-8 and IL-10 in HSPN patients
The r values of IL-8, IL-10, TNF-α and urinary protein were 0.61, 0.413 and 0.428, respectively, and the test standard was α=0.05 (Table II and Fig. 5).
Discussion
Henoch-Schonlein purpura (HSP) is the most common small vasculitis in childhood, which mainly causes skin, bowel and kidney changes (6,7). Although the pathogenesis is not clear currently, in various related research on the pathogenesis, cytokines have proven to have a certain role on the development of the disease. Clinical experiments have confirmed that cytokines such as TNF-α, IL-8 and IL-10 are involved in the pathogenesis of HSP (8,9). They are likely to be released by vascular endothelial cells, which trigger and promote the inflammatory response. These proinflammatory factors are stimulated and release chemokines, adsorbing inflammatory cells, inducing the expression of endothelial cell adhesion molecules, promoting the adhesion of endothelial cells to vascular walls (10,11).
IL-8 is a cytokine that appears in the acute phase of HSP, mainly infiltrated by peripheral leukocytes and polymorphonuclear cells, released to activate endothelial cells (12), which is also a protein peptide. Elevated levels of IL-8 in serum cause neutrophil chemotaxis and release associated proteases, causing systemic small vessel damage (13). The results of the present study show that serum IL-8 levels in patients with HSPN are significantly higher than those of NHSPN and normal healthy individuals, and IL-8 is correlated with HSPN urine protein content. Since the content of urine protein and the degree of renal function impairment were positively correlated, IL-8 is closely associated with the pathogenesis of HSP with nephritis. IL-10, as an immune regulator secreted by TH2 cells, mainly plays anti-inflammatory and immunosuppressive roles (14). Kimura et al have confirmed that serum levels of IL-10 in patients with HSP mainly exert an inhibitory effect on the antigen-presenting function of macrophages, and can effectively inhibit the production of other proinflammatory factors (15).
This study confirmed that serum IL-10 levels in HSPN patients were significantly higher than those in NHSPN and healthy individuals, and its content was positively correlated with the level of urine protein, which indicates the degree of renal function impairment, suggesting that IL-10 is involved in the pathogenesis of HSP, especially playing a greater role in the combination of renal dysfunction. TNF-α is an effective proinflammatory cytokine produced by a variety of cell types, including monocytes/macrophages, mesangial cells and renal epithelial cells. TNF-α can also cause changes in renal endothelial and mesangial cells (16). Previous findings have found that serum TNF-α levels are elevated in HSP patients, suggesting that cytokine TNF-α may be involved in vascular injury (17). Yang et al have shown that the activation of inflammatory cells in glomerular and renal interstitial cells can lead to local TNF-α production, leading to glomerular barrier damage and increased permeability (18).
The present findings have shown that serum TNF-α levels in patients with HSPN were significantly higher than the NHSPN and control group. TNF-α levels in the HSPN group serum was significantly higher than that in the NHSPN group. Urinary protein content also increased correspondingly, indicating that TNF-α and HSP renal function impairment is closely related (19,20). Urine protein is an indicator of renal dysfunction, and with the increase in urinary protein level, the degree of renal function damage also increases. Thus, the above three inflammatory immune factors are involved in kidney function impairment. Our results showed that the levels of TNF-α, IL-8 and IL-10 in the severe nephritis group (acute nephritis, chronic nephritis and nephrotic syndrome groups) were higher than those in the light nephritis group (i.e., simple proteinuria group) (P<0.05, P<0.01). The levels of TNF-α, IL-8 and IL-10 in the acute nephritis group were higher than those in the chronic nephritis and nephrotic syndrome groups.
In summary, the pathogenesis of HSP is complex, serum TNF-α, IL-8, and IL-10 in acute phase HSP patients was significantly higher than that in the healthy group. The TNF-α level in the HSPN group was significantly higher than that in the NHSPN group, indicating that TNF-α may cause a series of functions and morphological changes in glomerular cells. Therefore, serum TNF-α concentration can be used as an indicator of disease activity.
Acknowledgements
Not applicable.
Funding
No funding was received.
Availability data and materials
All data generated or analyzed during this study are included in this published article.
Authors' contributions
LY and QW analyzed and interpreted the patients data. SZ wrote the manuscript. LZ revised the manuscript for important intellectual content. SZ and LZ contributed to the conception and design of the study. All authors read and approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the Ethics Committee of The Affiliated Hospital of Jining Medical University (Shandong, China). Signed written informed consents were obtained from all the participants before the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
Saulsbury FT: Henoch-Schönlein purpura. Curr Opin Rheumatol. 13:35–40. 2001. View Article : Google Scholar : PubMed/NCBI | |
Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT and Chiang BL: A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology (Oxford). 44:618–622. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ballinger S: Henoch-Schonlein purpura. Curr Opin Rheumatol. 15:591–594. 2003. View Article : Google Scholar : PubMed/NCBI | |
Sano H, Izumida M, Shimizu H and Ogawa Y: Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr. 161:196–201. 2002. View Article : Google Scholar : PubMed/NCBI | |
Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 33:1114–1121. 1990. View Article : Google Scholar : PubMed/NCBI | |
Wu JJ, Zhu YT and Hu YM: Mechanism of feedback regulation of neutrophil inflammation in Henoch-Schönlein purpura. Eur Rev Med Pharmacol Sci. 20:4277–4285. 2016.PubMed/NCBI | |
Knight JF: The rheumatic poison: A survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura. Pediatr Nephrol. 4:533–541. 1990. View Article : Google Scholar : PubMed/NCBI | |
Zheng WJ, Chen MG, Chen XY, Yang Q and Lin RX: Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi. 12:120–122. 2010.(In Chinese). PubMed/NCBI | |
Wu TH, Wu SC, Huang TP, Yu CL and Tsai CY: Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron. 74:79–88. 1996. View Article : Google Scholar : PubMed/NCBI | |
Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A, Picco P and Pistoia V: Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus. J Rheumatol. 27:2251–2255. 2000.PubMed/NCBI | |
Bradley JR, Lockwood CM and Thiru S: Endothelial cell activation in patients with systemic vasculitis. QJM. 87:741–745. 1994. View Article : Google Scholar : PubMed/NCBI | |
Montefort S, Holgate ST and Howarth PH: Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J. 6:1044–1054. 1993.PubMed/NCBI | |
Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M and Pilatte Y: Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 114: 468–476, 1998? Clin Exp Immunol 114: 468–476, 1998. 114: 468–476, 1998:468-476, 1998–476, 1998. 1998. | |
Gardner-Medwin JM, Dolezalova P, Cummins C and Southwood TR: Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 360:1197–1202. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kimura S, Takeuchi S, Soma Y and Kawakami T: Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura. Clin Exp Dermatol. 38:730–736. 2013. View Article : Google Scholar : PubMed/NCBI | |
Tong YF, Liu Y, Hu ZX, Li ZC and Agula A: Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway. Exp Ther Med. 11:277–282. 2016. View Article : Google Scholar : PubMed/NCBI | |
López-Mejías R, Genre F, Pérez BS, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez S, Mijares V, Pina T, et al: HLA-DRB1 association with Henoch-Schonlein purpura. Arthritis Rheumatol. 67:823–827. 2014. View Article : Google Scholar | |
Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ and Chiang BL: Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol. 122:285–290. 2000. View Article : Google Scholar : PubMed/NCBI | |
Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K and Yabuta K: Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr. 151:44–47. 1992. View Article : Google Scholar : PubMed/NCBI | |
Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S and Freeman BA: Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol. 257:L399–L410. 1989.PubMed/NCBI |